Infection or inflammation at individual level as measured by C‐reactive protein (CRP) (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
Active range of motion (shoulder abduction) without pain. Scale: 0 to 180 degrees№ of participants: 143(3 RCTs) · rotator cuff disease
1 finding from 1 review
Active range of motion (shoulder abduction) without pain. Scale: 0 to 180 degrees№ of participants: 143(3 RCTs) · rotator cuff disease
1 finding from 1 review
Total active motion · adults (> 18 years of age) with trigger finger
1 finding from 1 review
Intervention not reported
No active intervention(2 RCTs, 256 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes no active intervention(2 RCTs, 256 participants) (very low certainty).
1 finding from 1 review
OR 0.28 [0.02, 2.91]
Studies not reported
Very low
Intervention not reported
No active intervention(No direct RCT) · people with liver cirrhosis and oesophageal varices with no history of bleeding
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
No active intervention(1 RCT, 161 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes no active intervention(1 RCT, 161 participants) (very low certainty).
1 finding from 1 review
HR 1.36 [0.35, 5.8]
Studies not reported
Very low
Intervention not reported
No active intervention(1 RCT, 140 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes no active intervention(1 RCT, 140 participants) (very low certainty).
1 finding from 1 review
HR 1.14 [0.56, 2.4]
Studies not reported
Very low
Intervention not reported
No active intervention(2 RCTs, 208 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes no active intervention(2 RCTs, 208 participants) (very low certainty).
1 finding from 1 review
HR 2.71 [0.97, 7.68]
Studies not reported
Very low
Intervention not reported
No active intervention(10 RCTs, 1200 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
The intervention may leads to higher no active intervention(10 RCTs, 1200 participants) (low certainty).
1 finding from 1 review
HR 2.04 [1.5, 2.78]
Studies not reported
Low
Intervention not reported
No active intervention(1 RCT; 40 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention may leads to lower no active intervention(1 RCT; 40 participants) (low certainty).
1 finding from 1 review
OR 0.22 [0.05, 0.86]
Studies not reported
Low
Intervention not reported
No active intervention(No direct RCT) · people with liver cirrhosis and previous oesophageal variceal bleeding
It is very uncertain whether the intervention changes no active intervention(No direct RCT) (very low certainty).
1 finding from 1 review
HR 1.19 [0, 1726.76]
Studies not reported
Very low
Intervention not reported
No active intervention(3 RCTs; 296 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention probably leads to higher no active intervention(3 RCTs; 296 participants) (moderate certainty).
1 finding from 1 review
HR 1.61 [1.01, 2.86]
Studies not reported
Moderate
Intervention not reported
No active intervention(4 RCTs; 412 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention showed no clear difference in no active intervention(4 RCTs; 412 participants) (low certainty).
1 finding from 1 review
HR 1.2 [0.83, 1.84]
Studies not reported
Low
Intervention not reported
No active intervention · people with nonalcohol‐related fatty liver disease (NAFLD)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
No active intervention · people with non‐alcohol‐related fatty liver disease (NAFLD)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of responders · IBD patients
IV iron sucrose showed no clear difference in number of responders ‐ active or inactive disease (6 weeks) compared with oral iron sulphate (low certainty).
1 finding from 1 review
Number of responders · IBD patients
It is very uncertain whether IM erythropoietin changes number of responders ‐ active disease (12 weeks) compared with oral placebo (very low certainty).
1 finding from 1 review
Number of responders · IBD patients
1 finding from 1 review
Serious adverse events ‐ active or inactive disease (14 days) · IBD patients
It is very uncertain whether oral iron sulphate changes serious adverse events ‐ active or inactive disease (14 days) compared with oral iron hydroxide polymaltose complex (very low certainty).
1 finding from 1 review